Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
RxSight (RXST)
NASDAQ:RXST
Holding RXST?
Track your performance easily
RXST Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$20.66 - $66.54
Previous Close$50.38
Volume227.41K
Average Volume (3M)463.65K
Market Cap
$2.00B
Enterprise Value$1.77B
Total Cash (Recent Filing)$233.28M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.63
Next Earnings
Nov 07, 2024EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.01
Shares Outstanding39,682,804
10 Day Avg. Volume266,987
30 Day Avg. Volume463,649
Standard Deviation0.16
R-Squared0.15
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)7.26
Price to Sales (P/S)17.36
Price to Cash Flow (P/CF)-124.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue15.33
Enterprise Value/Gross Profit32.85
Enterprise Value/Ebitda-151.23
Forecast
1Y Price Target
$63.00Price Target Upside25.05% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
RxSight News
Bulls Say, Bears Say
Bulls Say
EarningsRXST had a strong Q2, with sales running c. +7.8% ahead of the street at $34.9mn (+68.0% YoY), on particularly strong LDD placements.
Market PositionRXST is disrupting (and expanding) the premium IOL market in the US.
Product ExpansionRXST is set to see the label on its LAL+ offering expand to the largest range of any spherical lens, potentially helping drive adoption amongst especially high myopes.
Bears Say
Financial PerformanceRXST has negative net income in the forecast through 2025.
Market SpeculationThere is potential future overhang on the stock from market speculation to an eventual equity raise.
Price TargetLowered price target to $54 from $75 due to recent industry-wide issues.
---
Ownership Overview
4.91% Insiders
18.53% Mutual Funds
0.62% Other Institutional Investors
60.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RXST FAQ
What was RxSight’s price range in the past 12 months?
RxSight lowest stock price was $20.66 and its highest was $66.54 in the past 12 months.
What is RxSight’s market cap?
Currently, no data Available
When is RxSight’s upcoming earnings report date?
RxSight’s upcoming earnings report date is Nov 07, 2024 which is today.
How were RxSight’s earnings last quarter?
RxSight released its earnings results on Aug 05, 2024. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.223 by $0.063.
Is RxSight overvalued?
According to Wall Street analysts RxSight’s price is currently Undervalued.
Does RxSight pay dividends?
RxSight does not currently pay dividends.
What is RxSight’s EPS estimate?
RxSight’s EPS estimate is -$0.23.
How many shares outstanding does RxSight have?
RxSight has 39,682,804 shares outstanding.
What happened to RxSight’s price movement after its last earnings report?
RxSight reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.223. Following the earnings report the stock price went up 17.337%.
Which hedge fund is a major shareholder of RxSight?
Among the largest hedge funds holding RxSight’s share is RA Capital Management. It holds RxSight’s shares valued at 222M.
---
RxSight Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$63.00 (25.05% Upside)
$63.00 (25.05% Upside)
Blogger Sentiment
Bullish
RXST Sentiment 80%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 719.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
126.12%
12-Months-Change
Fundamentals
Return on Equity
-17.01%
Trailing 12-Months
Asset Growth
56.46%
Trailing 12-Months
Company Description
RxSight
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.
---
RXST Earnings Call
Q2 2024
0:00 / 0:00
---
RXST Stock 12 Month Forecast
Average Price Target
$63.00
▲(25.05% Upside)
Technical Analysis
Akero Therapeutics
―
ALX Oncology Holdings
―
Kiniksa Pharmaceuticals
―
Syndax Pharmaceuticals
―
Best Analysts Covering RXST
1 Year
1 Year Success Rate
15/19 ratings generated profit
1 Year Average Return
+88.57%
reiterated a buy rating 2 months ago
Copying David Saxon's trades and holding each position for 1 Year would result in 78.95% of your transactions generating a profit, with an average return of +88.57% per trade.
---